Jensen, A., & Debus, J. (2019). Cost-effectiveness analysis (CEA) of IMRT plus C12 boost vs IMRT only in adenoid cystic carcinoma (ACC) of the head and neck. Radiation oncology, 14, . https://doi.org/10.1186/s13014-019-1395-9
Chicago-Zitierstil (17. Ausg.)Jensen, Alexandra, und Jürgen Debus. "Cost-effectiveness Analysis (CEA) of IMRT Plus C12 Boost Vs IMRT Only in Adenoid Cystic Carcinoma (ACC) of the Head and Neck." Radiation Oncology 14 (2019). https://doi.org/10.1186/s13014-019-1395-9.
MLA-Zitierstil (9. Ausg.)Jensen, Alexandra, und Jürgen Debus. "Cost-effectiveness Analysis (CEA) of IMRT Plus C12 Boost Vs IMRT Only in Adenoid Cystic Carcinoma (ACC) of the Head and Neck." Radiation Oncology, vol. 14, 2019, https://doi.org/10.1186/s13014-019-1395-9.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.